Could we reduce renal toxicity of [177Lu]Lu-PSMA radioligand therapy with furosemide?

Saved in:
Bibliographic Details
Title: Could we reduce renal toxicity of [177Lu]Lu-PSMA radioligand therapy with furosemide?
Authors: Pop SG; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland., Strobel K; Department of Nuclear Medicine and Radiology, Luzerner Kantonsspital, University Teaching and Research Hospital, University of Lucerne, Lucerne, Switzerland., Heimer J; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland.; Digital Trial Intervention Plattform (dTIP), ETH Zurich, Zurich, Switzerland., Baumann C; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland., Omlin A; Onkozentrum Zurich, University of Zurich and Tumorzentrum Hirslanden Zurich, Zurich, Switzerland., Leike T; Department of Nuclear Medicine and Radiology, Luzerner Kantonsspital, University Teaching and Research Hospital, University of Lucerne, Lucerne, Switzerland., Spielhofer N; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland., Popescu CE; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland., Zander A; Department of Nuclear Medicine and Radiology, Luzerner Kantonsspital, University Teaching and Research Hospital, University of Lucerne, Lucerne, Switzerland., Burger IA; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland. Irene.burger@ksb.ch.; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Irene.burger@ksb.ch.; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland. Irene.burger@ksb.ch.
Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2026 Jul; Vol. 53 (9), pp. 5427-5435. Date of Electronic Publication: 2026 Apr 01.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1619-7089
DOI:10.1007/s00259-026-07865-8